What this means
The peptide supplement market has experienced rapid growth due to marketing claims of enhanced performance and accelerated recovery from musculoskeletal injury. These peptides are increasingly popular with patients and athletes and are often perceived as low risk, despite the absence of efficacy or safety data for many emerging peptides.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- Not stated
- Kind of research
- A study
The science
- Original title
- Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
- Authors
- Tewari K, Liu TP, Im C et al.
- Journal
- The American journal of sports medicine
- Published
- Aug 11, 2026
- Study type
- Study
- PMID
- 42578445 ↗
Abstract
Background
The peptide supplement market has experienced rapid growth due to marketing claims of enhanced performance and accelerated recovery from musculoskeletal injury. These peptides are increasingly popular with patients and athletes and are often perceived as low risk, despite the absence of efficacy or safety data for many emerging peptides. To summarize existing peer-reviewed data on 6 emerging peptides (BPC-157, thymosin beta-4 or TB-500, CJC-1295, MK-677, ipamorelin, and GHK-Cu [copper peptide]) for musculoskeletal recovery and enhancement in animal and human models.
What they did
Scoping review. Three independent reviewers searched the PubMed database using permutations of peptide search terms (BPC-157, TB-500, CJC-1295, MK-677 [ibutamoren], ipamorelin, and GHK-Cu) combined with musculoskeletal tissue search terms (bone, fracture, muscle, tendon, ligament, meniscus, and cartilage) following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Papers were independently screened by 2 reviewers, with a third serving as a tiebreaker. Papers examining these peptides for musculoskeletal treatment, tissue recovery, or performance in animal or human models were included.
What they found
Overall, 67% of identified publications utilized preclinical animal models. In animal models, most commonly rats, each compound demonstrated unique mechanisms with promising but variable effects on tendon, muscle, bone, and ligament healing. Human clinical studies were limited to a handful of investigations, most lacking robust controls or rigorous study designs. Human data were heterogeneous and revealed modest improvements at best for metabolic bone health and degenerative knee pain. Some peptides such as MK-677 were associated with significant risks including congestive heart failure, and significant heterogeneity existed in dosing and route of administration. Despite promising findings in animal studies, the claimed benefits of emerging peptide supplements for musculoskeletal recovery and performance remain unsubstantiated by current human trials. Documented risks include cardiovascular complications and metabolic dysfunction such as insulin resistance. Because of the lack of robust efficacy and safety data, peptide supplements should not currently be recommended as a replacement or adjunct for existing orthopaedic standard of care.
The authors' abstract, grouped under plain headings from its own section labels.
Tewari K, Liu TP, Im C et al. Peptide Supplements and Their Therapeutic Applications in Sports Medicine. The American journal of sports medicine. 2026. doi:10.1177/03635465261464420. PMID: 42578445. https://pubmed.ncbi.nlm.nih.gov/42578445/
Related research
Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome.
BACKGROUND: Diabetic foot syndrome (DFS) is characterized by chronic inflammation, thrombotic imbalance, and impaired wound healing, yet systemic molecular alterations underlying this complication remain incompletely…
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.
A modified form of thymosin beta 4 helped heart tissue after heart attack in animals
Researchers changed a protein so it stays in the body longer and tested it for heart attack damage. This study was done in animals, so it does not show the same effect in people.
Review of copper peptide GHK-Cu studies finds many lab results but few human trials
Researchers read 64 studies on GHK-Cu, a copper-linked peptide, and found much lab and animal work. They say well-designed human trials using microneedles are still needed.
A skin mix with GHK-Cu may help wrinkles and skin barrier in tests
Researchers tested a mix of a ferment extract and a copper peptide for skin aging. The results suggest it may help, but these early tests do not prove it works for everyone.
Review of a copper peptide used in skin treatments
Researchers reviewed 20 studies on GHK-Cu, a copper peptide, for skin and beauty uses. Most were lab or animal studies, and only two were human trials, so more strong testing is still needed.
See all research on GHK-Cu (copper peptide) →